Jane Skjøth-Rasmussen

Consultant Neurosurgeon, Head of Oncological Neurosurgery

Denmark

Research Interests

Explore related searches

Professors in Medical Imaging

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jane Skjøth-Rasmussen is a Consultant Neurosurgeon and Head of Oncological Neurosurgery at Rigshospitalet Neurocentret. She is based in Denmark, where her research primarily focuses on glioma treatment, including the evaluation of novel imaging agents and immunotherapy approaches. Recent publications reflect her expertise in the societal impact of neuro-oncological conditions and postoperative outcomes in brain surgery.

Articles (11)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Collaborators (7)

Michael Bachmann Nielsen

Københavns Universitet

DENMARK

View details

Kristoffer Vitting-Seerup

Technical University of Denmark

DENMARK

View details

Kasper Amund Henriksen

Københavns Universitet

DENMARK

View details

Alessio Locallo

Københavns Universitet

DENMARK

View details

Frantz Rom Poulsen

Consultant/professor

Odense Universitetshospital

DENMARK

View details

Anouk Kirsten Trip

Aarhus University Hospital

DENMARK

View details

Adam Espe Hansen

Copenhagen University Hospital

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jane Skjøth-Rasmussen

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Evaluating work activity and societal burden in patients with grade 2 IDH-mutant glioma

Novel Urokinase-Type Plasminogen Activator Receptor-Targeting Optical Imaging Agent ICG-Glu-Glu-AE105 for Visualization of Malignant Glioma During Surgery: First-in-Human Study in 35 Patients with Brain Cancer

Blood-brain barrier disruption following MR-guided laser interstitial thermal therapy

Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways

Immunotherapy drives mesenchymal tumor cell state shift and TME immune response in glioblastoma patients

Patterns of care and survival in patients with multifocal glioblastoma: A Danish cohort study

Timing of Early Postoperative MRI following Primary Glioblastoma Surgery—A Retrospective Study of Contrast Enhancements in 311 Patients

Assessment of the Milan Complexity Scale for prediction of postoperative morbidity in pediatric neuro-oncological surgery

CNS infection in children with brain tumors: adding ventriculostomy to brain tumor resection increases risk more than 20-fold

Response to the commentary on our work: a new uPAR-targeting fluorescent probe for optical guided intracranial surgery in resection of a meningioma—a case report

Perspective: targeting VEGF-A and YKL-40 in glioblastoma – matter matters

Collaborators (7)

Michael Bachmann Nielsen

Kristoffer Vitting-Seerup

Kasper Amund Henriksen

Alessio Locallo

Frantz Rom Poulsen

Anouk Kirsten Trip

Adam Espe Hansen

Make your next move.